0001104659-23-099294.txt : 20230908
0001104659-23-099294.hdr.sgml : 20230908
20230908160831
ACCESSION NUMBER: 0001104659-23-099294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230906
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PETERS WILLIAM J
CENTRAL INDEX KEY: 0001263136
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 231245360
MAIL ADDRESS:
STREET 1: C/O AMPHASTAR PHARMACEUTICALS, INC.
STREET 2: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
tm2325705-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-09-06
0
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001263136
PETERS WILLIAM J
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
0
0
CFO, EVP & Treasurer
1
Common Stock
2023-09-06
4
M
0
10000
19.79
A
115603
D
Common Stock
2023-09-06
4
M
0
21250
20.23
A
136853
D
Common Stock
2023-09-06
4
M
0
25250
13.03
A
162103
D
Common Stock
2023-09-06
4
S
0
60684
51.7453
D
101419
D
Common Stock
2023-09-06
4
S
0
59
52.2606
D
101360
D
Employee Stock Option (right to buy)
19.79
2023-09-06
4
M
0
10000
0
D
2028-03-15
Common Stock
10000
5053
D
Employee Stock Option (right to buy)
20.23
2023-09-06
4
M
0
21250
0
D
2029-03-15
Common Stock
21250
36475
D
Employee Stock Option (right to buy)
13.03
2023-09-06
4
M
0
25250
0
D
2030-03-16
Common Stock
25250
69100
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.26 to $52.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.26 to $52.265, inclusive.
Shares subject to the option are fully vested and immediately exercisable.
Shares subject to the option vest in four equal annual installments beginning on March 16, 2021.
/s/ William J. Peters
2023-09-08